Table 2. Expression of PD-L1 in patients with pancreaticobiliary ASC and AC.
Case No. | Age (years) | Sex | Tissue | Histologic type [% of SC] | PD-L1 TPS | Cancer-immune phenotype | ||
---|---|---|---|---|---|---|---|---|
Source | Type | AC [%] | SC [%] | |||||
1 | 72 | F | Panc | FNB | ASC [80] | Low [5] | 0 | IE |
2 | 78 | M | Panc | FNB | ASC [50] | 0 | 0 | ID |
3 | 67 | M | Panc | FNB | ASC [60] | 0 | Low [30] | ID |
4 | 69 | M | Panc | FNA | ASC [90] | 0 | 0 | IE |
5 | 65 | F | Panc | Resection | ASC [50] | Low [1] | Low [30] | IE |
6 | 52 | M | Panc | Resection | ASC [60] | 0 | 0 | IE |
7 | 72 | M | Panc | Resection | ASC [80] | 0 | Low [5] | IE |
8 | 46 | M | Panc | Resection | ASC [40] | High [60] | High [60] | II |
9 | 46 | M | Panc | Resection | ASC [25] | 0 | High [60] | IE |
10 | 70 | F | Panc | Resection | ASC [40] | Low [20] | Low [30] | ID |
11 | 60 | F | Gb | Resection | ASC [60] | 0 | Low [20] | IE |
12 | 67 | F | Gb | Resection | ASC [80] | 0 | Low [10] | IE |
13 | 92 | M | Gb | Resection | ASC [60] | 0 | 0 | IE |
14 | 58 | F | Gb | Resection | ASC [30] | 0 | 0 | ID |
15 | 50 | M | Gb | Resection | ASC [40] | 0 | High [60] | II |
16 | 46 | M | Panc | Resection | AC [0] | 0 | NA | ID |
17 | 57 | F | Panc | Resection | AC [0] | High [60] | NA | IE |
18 | 78 | F | Panc | Resection | AC [0] | 0 | NA | IE |
19 | 69 | F | Panc | Resection | AC [0] | 0 | NA | ID |
20 | 50 | M | Panc | Resection | AC [0] | 0 | NA | IE |
21 | 44 | M | Panc | Resection | AC [0] | 0 | NA | ID |
22 | 53 | M | Panc | Resection | AC [0] | 0 | NA | ID |
23 | 74 | M | Panc | Resection | AC [0] | 0 | NA | ID |
24 | 65 | F | Panc | Resection | AC [0] | 0 | NA | ID |
25 | 60 | M | Panc | Resection | AC [0] | 0 | NA | ID |
26 | 75 | F | Panc | Resection | AC [0] | 0 | NA | ID |
27 | 71 | F | Panc | Resection | AC [0] | 0 | NA | ID |
28 | 62 | F | Panc | Resection | AC [0] | Low [30] | NA | IE |
29 | 66 | M | Panc | Resection | AC [0] | 0 | NA | ID |
30 | 61 | F | Panc | Resection | AC [0] | 0 | NA | ID |
31 | 75 | F | Panc | Resection | AC [0] | 0 | NA | ID |
32 | 64 | F | Panc | Resection | AC [0] | 0 | NA | ID |
33 | 53 | M | Panc | Resection | AC [0] | 0 | NA | ID |
34 | 72 | F | Panc | Resection | AC [0] | 0 | NA | ID |
35 | 75 | M | Panc | Resection | AC [0] | 0 | NA | ID |
36 | 77 | M | Panc | Resection | AC [0] | 0 | NA | ID |
37 | 70 | F | Panc | Resection | AC [0] | 0 | NA | IE |
38 | 64 | F | Gb | Resection | AC [0] | 0 | NA | ID |
39 | 70 | F | Gb | Resection | AC [0] | 0 | NA | IE |
40 | 74 | F | Gb | Resection | AC [0] | Low [30] | NA | II |
41 | 58 | F | Gb | Resection | AC [0] | 0 | NA | IE |
42 | 70 | F | Gb | Resection | AC [0] | 0 | NA | ID |
43 | 54 | F | Gb | Resection | AC [0] | 0 | NA | ID |
44 | 74 | F | Gb | Resection | AC [0] | 0 | NA | IE |
45 | 86 | F | Gb | Resection | AC [0] | 0 | NA | ID |
46 | 50 | M | Gb | Resection | AC [0] | 0 | NA | IE |
47 | 61 | F | Gb | Resection | AC [0] | 0 | NA | IE |
48 | 78 | M | Gb | Resection | AC [0] | 0 | NA | ID |
49 | 74 | F | Gb | Resection | AC [0] | 0 | NA | IE |
PD-L1, programmed cell death ligand 1; ASC, adenosquamous carcinoma; AC, adenocarcinoma; SC, squamous cell carcinoma; TPS, tumor proportion score; F, female; M, male; Panc, pancreas; Gb, gallbladder; FNB, fine needle biopsy; FNA, fine needle aspiration; IE, immune exclusive; ID, immune desert; II, immune inflamed.